These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 25264042

  • 1. Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: comparison of clinical results obtained with BNCT and conventional treatment.
    Kageji T, Nagahiro S, Mizobuchi Y, Matsuzaki K, Nakagawa Y, Kumada H.
    J Med Invest; 2014; 61(3-4):254-63. PubMed ID: 25264042
    [Abstract] [Full Text] [Related]

  • 2. Clinical results of boron neutron capture therapy (BNCT) for glioblastoma.
    Kageji T, Mizobuchi Y, Nagahiro S, Nakagawa Y, Kumada H.
    Appl Radiat Isot; 2011 Dec; 69(12):1823-5. PubMed ID: 21684170
    [Abstract] [Full Text] [Related]

  • 3. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S, Miyatake S, Nonoguchi N, Hiramatsu R, Iida K, Miyata S, Yokoyama K, Doi A, Kuroda Y, Kuroiwa T, Michiue H, Kumada H, Kirihata M, Imahori Y, Maruhashi A, Sakurai Y, Suzuki M, Masunaga S, Ono K.
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [Abstract] [Full Text] [Related]

  • 4. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A, Yamamoto T, Tsurubuchi T, Matsuda M, Shirakawa M, Nakai K, Endo K, Tokuue K, Tsuboi K.
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [Abstract] [Full Text] [Related]

  • 5. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT, Swedish Brain Tumour Study Group.
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [Abstract] [Full Text] [Related]

  • 6. Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.
    Joensuu H, Kankaanranta L, Seppälä T, Auterinen I, Kallio M, Kulvik M, Laakso J, Vähätalo J, Kortesniemi M, Kotiluoto P, Serén T, Karila J, Brander A, Järviluoma E, Ryynänen P, Paetau A, Ruokonen I, Minn H, Tenhunen M, Jääskeläinen J, Färkkilä M, Savolainen S.
    J Neurooncol; 2003 Aug; 62(1-2):123-34. PubMed ID: 12749708
    [Abstract] [Full Text] [Related]

  • 7. Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential.
    Hopewell JW, Gorlia T, Pellettieri L, Giusti V, H-Stenstam B, Sköld K.
    Appl Radiat Isot; 2011 Dec; 69(12):1737-40. PubMed ID: 21482122
    [Abstract] [Full Text] [Related]

  • 8. Boron neutron capture therapy for newly diagnosed glioblastoma.
    Kawabata S, Miyatake S, Kuroiwa T, Yokoyama K, Doi A, Iida K, Miyata S, Nonoguchi N, Michiue H, Takahashi M, Inomata T, Imahori Y, Kirihata M, Sakurai Y, Maruhashi A, Kumada H, Ono K.
    J Radiat Res; 2009 Jan; 50(1):51-60. PubMed ID: 18957828
    [Abstract] [Full Text] [Related]

  • 9. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Wielopolski L, Chanana AD.
    Int J Radiat Oncol Biol Phys; 1998 Mar 01; 40(4):829-34. PubMed ID: 9531367
    [Abstract] [Full Text] [Related]

  • 10. An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme.
    Pellettieri L, H-Stenstam B, Rezaei A, Giusti V, Sköld K.
    Acta Neurol Scand; 2008 Mar 01; 117(3):191-7. PubMed ID: 18297764
    [Abstract] [Full Text] [Related]

  • 11. Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential.
    Sköld K, Gorlia T, Pellettieri L, Giusti V, H-Stenstam B, Hopewell JW.
    Br J Radiol; 2010 Jul 01; 83(991):596-603. PubMed ID: 20603410
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view.
    Diaz AZ.
    J Neurooncol; 2003 Jul 01; 62(1-2):101-9. PubMed ID: 12749706
    [Abstract] [Full Text] [Related]

  • 15. Histopathological findings in autopsied glioblastoma patients treated by mixed neutron beam BNCT.
    Kageji T, Nagahiro S, Uyama S, Mizobuchi Y, Toi H, Nakamura M, Nakagawa Y.
    J Neurooncol; 2004 May 01; 68(1):25-32. PubMed ID: 15174518
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme--study design and current status report.
    Kawabata S, Miyatake S, Hiramatsu R, Hirota Y, Miyata S, Takekita Y, Kuroiwa T, Kirihata M, Sakurai Y, Maruhashi A, Ono K.
    Appl Radiat Isot; 2011 Dec 01; 69(12):1796-9. PubMed ID: 21459588
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma.
    Kondo N, Barth RF, Miyatake SI, Kawabata S, Suzuki M, Ono K, Lehman NL.
    J Neurooncol; 2017 May 01; 133(1):107-118. PubMed ID: 28534152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.